273 related articles for article (PubMed ID: 32805259)
1. Neonatal Abstinence Syndrome Severity Index Predicts 18-Month Neurodevelopmental Outcome in Neonates Randomized to Morphine or Methadone.
Flannery T; Davis JM; Czynski AJ; Dansereau LM; Oliveira EL; Camardo SA; Lester BM
J Pediatr; 2020 Dec; 227():101-107.e1. PubMed ID: 32805259
[TBL] [Abstract][Full Text] [Related]
2. Neurodevelopmental Outcomes of Neonates Randomized to Morphine or Methadone for Treatment of Neonatal Abstinence Syndrome.
Czynski AJ; Davis JM; Dansereau LM; Engelhardt B; Marro P; Bogen DL; Hudak ML; Shenberger J; Wachman EM; Oliveira EL; Lester BM
J Pediatr; 2020 Apr; 219():146-151.e1. PubMed ID: 31987653
[TBL] [Abstract][Full Text] [Related]
3. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
Kaltenbach K; Holbrook AM; Coyle MG; Heil SH; Salisbury AL; Stine SM; Martin PR; Jones HE
Addiction; 2012 Nov; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926
[TBL] [Abstract][Full Text] [Related]
4. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome.
Young ME; Hager SJ; Spurlock D
Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S162-7. PubMed ID: 26582303
[TBL] [Abstract][Full Text] [Related]
5. The relationship between gestational age and the severity of neonatal abstinence syndrome.
Gibson KS; Stark S; Kumar D; Bailit JL
Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
[TBL] [Abstract][Full Text] [Related]
6. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
Gaalema DE; Scott TL; Heil SH; Coyle MG; Kaltenbach K; Badger GJ; Arria AM; Stine SM; Martin PR; Jones HE
Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927
[TBL] [Abstract][Full Text] [Related]
7. Opioid treatment for opioid withdrawal in newborn infants.
Zankl A; Martin J; Davey JG; Osborn DA
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD002059. PubMed ID: 34231914
[TBL] [Abstract][Full Text] [Related]
8. Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
Coyle MG; Salisbury AL; Lester BM; Jones HE; Lin H; Graf-Rohrmeister K; Fischer G
Addiction; 2012 Nov; 107 Suppl 1(0 1):63-73. PubMed ID: 23106928
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.
Davis JM; Shenberger J; Terrin N; Breeze JL; Hudak M; Wachman EM; Marro P; Oliveira EL; Harvey-Wilkes K; Czynski A; Engelhardt B; D'Apolito K; Bogen D; Lester B
JAMA Pediatr; 2018 Aug; 172(8):741-748. PubMed ID: 29913015
[TBL] [Abstract][Full Text] [Related]
10. Neonatal abstinence syndrome after methadone or buprenorphine exposure.
Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Fischer G
N Engl J Med; 2010 Dec; 363(24):2320-31. PubMed ID: 21142534
[TBL] [Abstract][Full Text] [Related]
11. Management of neonatal abstinence syndrome in neonates born to opioid maintained women.
Ebner N; Rohrmeister K; Winklbaur B; Baewert A; Jagsch R; Peternell A; Thau K; Fischer G
Drug Alcohol Depend; 2007 Mar; 87(2-3):131-8. PubMed ID: 17000060
[TBL] [Abstract][Full Text] [Related]
12. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.
Metz V; Jagsch R; Ebner N; Würzl J; Pribasnig A; Aschauer C; Fischer G
Hum Psychopharmacol; 2011 Aug; 26(6):412-21. PubMed ID: 21823171
[TBL] [Abstract][Full Text] [Related]
13. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.
Pritham UA; Paul JA; Hayes MJ
J Obstet Gynecol Neonatal Nurs; 2012 Mar; 41(2):180-190. PubMed ID: 22375882
[TBL] [Abstract][Full Text] [Related]
14. Emerging therapies for the treatment of neonatal abstinence syndrome.
Frazier LM; Bobby LE; Gawronski KM
J Matern Fetal Neonatal Med; 2022 Mar; 35(5):987-995. PubMed ID: 32146833
[TBL] [Abstract][Full Text] [Related]
15. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
[TBL] [Abstract][Full Text] [Related]
16. Is Maternal Methadone Dose Associated with the Severity of Neonatal Abstinence Syndrome?
Smith J; Lafferty M; Boelig RC; Carola D; Adeniyi-Jones S; Kraft WK; Greenspan JS; Aghai ZH
Am J Perinatol; 2022 Jul; 39(10):1138-1144. PubMed ID: 33321531
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
[TBL] [Abstract][Full Text] [Related]
18. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome.
Hall ES; Wexelblatt SL; Crowley M; Grow JL; Jasin LR; Klebanoff MA; McClead RE; Meinzen-Derr J; Mohan VK; Stein H; Walsh MC;
Pediatrics; 2014 Aug; 134(2):e527-34. PubMed ID: 25070317
[TBL] [Abstract][Full Text] [Related]
19. Hospital morphine preparation for abstinence syndrome in newborns exposed to buprenorphine or methadone.
Colombini N; Elias R; Busuttil M; Dubuc M; Einaudi MA; Bues-Charbit M
Pharm World Sci; 2008 Jun; 30(3):227-34. PubMed ID: 18008179
[TBL] [Abstract][Full Text] [Related]
20. Treating Neonatal Abstinence Syndrome in a Rural Hospital: Lessons Learned.
Gadomski A; Riley M; Ramiza K; Onofrey L; Zinkievich R; Krupa N; Scribani M
Acad Pediatr; 2018; 18(4):425-429. PubMed ID: 29428413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
